James X. SotiropoulosVishal KapadiaMaximo VentoYacov RabiOla D. SaugstadR. Kishore KumarGeorg M. SchmölzerHuyan ZhangYuan YuanGina LimSatoshi KusudaTakeshi ArimitsuTinh Thu NguyenRatchada KitsommartKee Thai YeoJu Lee OeiUlsan University HospitalSiriraj HospitalUniversity of Medicine and Pharmacy VietnamHospital Universitari i Politècnic La FeKeio University School of MedicineKyorin UniversityUniversity of Alberta, Faculty of Medicine and DentistryKK Women's And Children's HospitalUT Southwestern Medical SchoolRoyal Alexandra Hospital, EdmontonUNSW MedicineUniversitetet i OsloNorthwestern UniversityRoyal Hospital for Women, SydneyUniversity of Pennsylvania Perelman School of MedicineUniversity of CalgaryCloudnine HospitalsGuangzhou Women and Children’s Medical CenterHealth Research Institute La Fe2022-08-042022-08-042021-12-01Acta Paediatrica, International Journal of Paediatrics. Vol.110, No.12 (2021), 3261-326816512227080352532-s2.0-85114677402https://repository.li.mahidol.ac.th/handle/20.500.14594/77531Aim: The aim of this study was to determine clinician opinion regarding oxygen management in moderate-late preterm resuscitation. Methods: An anonymous online questionnaire was distributed through email/social messaging platforms to neonatologists in 21 countries (October 2020-March 2021) via REDCap. Results: Of the 695 respondents, 69% had access to oxygen blenders and 90% had pulse oximeters. Respondents from high-income countries were more likely to have oxygen blenders than those from middle-income countries (72% vs. 66%). Most initiated respiratory support with FiO2 0.21 (43%) or 0.3 (36%) but only 45% titrated FiO2 to target SpO2. Most (89%) considered heart rate as a more important indicator of response than SpO2. Almost all (96%) supported the need for well-designed trials to examine oxygenation in moderate-late preterm resuscitation. Conclusion: Most clinicians resuscitated moderate-late preterm infants with lower initial FiO2 but some cannot/will not target SpO2 or titrate FiO2. Most consider heart rate as a more important indicator of infant response than SpO2.Large and robust clinical trials examining oxygen use for moderate-late preterm resuscitation, including long-term neurodevelopmental outcomes, are supported amongst clinicians.Mahidol UniversityMedicineOxygen for the delivery room respiratory support of moderate-to-late preterm infants. An international survey of clinical practice from 21 countriesArticleSCOPUS10.1111/apa.16091